Sector News

Linde buys U.S.-based respiratory therapies specialist

December 7, 2015
Chemical Value Chain

(Reuters) – German industrial gases maker Linde (LING.DE) said on Monday it agreed to acquire U.S.-based respiratory therapies specialist American HomePatient [HIAAMA.UL] from Highland Capital Management LP.

No financial details were disclosed.

The deal is expected to close in the first quarter of 2016.

American HomePatient had sales of about 260 million euros ($282 million) in the last financial year.

($1 = 0.9231 euros)

(Reporting by Christoph Steitz; Editing by James Regan)

Related News

March 6, 2021

New catalyst makes styrene manufacturing cheaper, greener

Chemical Value Chain

Chemical engineering researchers have developed a new catalyst that significantly increases yield in styrene manufacturing, while simultaneously reducing energy use and greenhouse gas emissions.

March 6, 2021

Haldor Topsoe to build large-scale SOEC electrolyzer manufacturing facility

Chemical Value Chain

With efficiencies above 90%, Topsoe’s proprietary SOEC electrolyzers offer superior performance in electrolysis of water into hydrogen, when compared to today’s standard alkaline or PEM electrolyzers.

March 6, 2021

Chevron Phillips names new CEO 

Chemical Value Chain

Chevron Phillips Chemical announced that Bruce Chinn, currently president, Chevron Chemicals, will become chief executive officer. B.J. Hebert, currently executive vice president and chief operating officer, will become president and chief operating officer.

Send this to a friend